APPENDIX I

ACCOUNTANTS’ REPORT

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT)

Attributable to BeiGene, Ltd.

Accumulated

Additional

Other

Paid-In
Capital

Comprehensive
Income/(loss)

Ordinary Shares

Shares

Amount

Accumulated

Deficit

Total

Non-

Controlling
Interests

Total

US$’000

US$’000

US$’000

US$’000

US$’000

US$’000

US$’000

18,227

(1,809)

(118,195)

(101,765)

— (101,765)

166,127

198,617

14,692

1,513

3,519

1,750

—

176,064

10,704

—

—

—

—

—

—

—

—

—

—

—

—

— 166,137

— 166,137

— 198,626

— 198,626

—

14,693

—

14,693

—

—

—

—

1,513

3,519

1,750

—

— 176,084

—

10,704

(119,217)

(119,217)

—

—

—

—

1,513

3,519

1,750

—

— 176,084

—

10,704

— (119,217)

—

863

863

—

863

591,213

(946)

(237,412)

352,907

— 352,907

188,513

149,925

23,606

—

42,863

—

4,627

—

—

—

—

—

—

—

—

—

729

—

— 188,517

— 188,517

— 149,928

— 149,928

—

—

—

—

—

—

23,606

—

42,863

—

4,627

729

(96,034)

(96,034)

—

23,606

14,527

—

—

—

103

167

14,527

42,863

—

4,627

832

(95,867)

1,000,747

(217)

(333,446)

667,143

14,797

681,940

Balance at December 31, 2015 ..........................

116,174,094

Issuance of ordinary shares in connection

with initial public offering (Note II.30)..

98,670,000

Issuance of ordinary shares in connection
with follow-on public offering (Note
II.30) .....................................................

Conversion of Senior Promissory Note

86,206,250

(Note II.30)............................................

7,942,314

Exercise of warrants in connection with

convertible promissory note (Notes II.17
and II.30) ...............................................

621,637

Exercise of option to purchase shares by

rental deferred (Note II.17) ....................

1,451,586

Exercise of warrants by Baker Bros. (Note

II.30) .....................................................

2,592,593

Issuance of shares reserved for share

options exercise .....................................

271,284

Conversion of preferred shares to ordinary

shares (Note II.30) .................................

199,990,641

Share-based compensation............................

1,913,210

Net loss .......................................................

Other comprehensive income .......................

—

—

Balance at December 31, 2016 ..........................

515,833,609

Issuance of ordinary shares in secondary
follow-on offering, net of transaction
costs (Note II.30) ...................................

Proceeds from sale of ordinary shares, net

36,851,750

of cost (Note II.30) ................................

32,746,416

Discount on the sale of ordinary shares

(Note II.4) .............................................

Contributions from shareholders (Note

II.11) .....................................................

Share-based compensation............................

Issuance of shares reserved for share

—

—

—

options exercise .....................................

787,571

Exercise of options ......................................

5,852,984

Other comprehensive income .......................

Net profit (loss)...........................................

—

—

Balance at December 31, 2017 ..........................

592,072,330

12

10

9

1

—

—

—

—

20

—

—

—

52

4

3

—

—

—

—

—

—

—

59

— I-11 —

